- Home
- SVRA vs ACTG Comparison
SVRA vs ACTG Comparison
Compare SVRA & ACTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- ACTG
- Stock Information
- Founded
- SVRA N/A
- ACTG 1993
- Country
- SVRA United States
- ACTG United States
- Employees
- SVRA N/A
- ACTG N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- ACTG Multi-Sector Companies
- Sector
- SVRA Health Care
- ACTG Miscellaneous
- Exchange
- SVRA Nasdaq
- ACTG Nasdaq
- Market Cap
- SVRA 458.2M
- ACTG 414.8M
- IPO Year
- SVRA N/A
- ACTG 1996
- Fundamental
- Price
- SVRA $2.69
- ACTG $4.21
- Analyst Decision
- SVRA Buy
- ACTG Strong Buy
- Analyst Count
- SVRA 7
- ACTG 1
- Target Price
- SVRA $9.86
- ACTG $7.00
- AVG Volume (30 Days)
- SVRA 633.7K
- ACTG 118.9K
- Earning Date
- SVRA 03-06-2025
- ACTG 03-13-2025
- Dividend Yield
- SVRA N/A
- ACTG N/A
- EPS Growth
- SVRA N/A
- ACTG N/A
- EPS
- SVRA N/A
- ACTG 0.39
- Revenue
- SVRA N/A
- ACTG $165,779,000.00
- Revenue This Year
- SVRA N/A
- ACTG N/A
- Revenue Next Year
- SVRA N/A
- ACTG $84.79
- P/E Ratio
- SVRA N/A
- ACTG $10.79
- Revenue Growth
- SVRA N/A
- ACTG 261.08
- 52 Week Low
- SVRA $2.59
- ACTG $3.92
- 52 Week High
- SVRA $5.70
- ACTG $5.74
- Technical
- Relative Strength Index (RSI)
- SVRA 40.81
- ACTG 40.48
- Support Level
- SVRA $2.65
- ACTG $4.30
- Resistance Level
- SVRA $2.91
- ACTG $4.38
- Average True Range (ATR)
- SVRA 0.11
- ACTG 0.11
- MACD
- SVRA 0.01
- ACTG 0.00
- Stochastic Oscillator
- SVRA 23.08
- ACTG 13.04
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, significant capital base, and deep industry relationships to drive value. Acacia evaluates opportunities based on the attractiveness of the underlying cash flows, without regard to a specific investment horizon. Acacia operates its businesses based on three key principles of people, process, and performance and has built a management team with demonstrated expertise in research, transactions and execution, and operations and management.